decorative nodes

Updates

April 13, 2021 · CNBC Worldwide Exchange with Brian Sullivan arrow icon

Former FDA Commissioner weighs in on the push to get more shots into American arms

Dr. Peggy Hamburg, former FDA Commissioner and assistant director of the National Institute of Allergy & Infectious Diseases, discusses how the rollout of COVID vaccines is racing against a rise in infections at home and abroad.

April 2, 2021

Response to American Jobs Plan

Science and technology are critical to our nation’s future, but America invests just 0.7 percent of GDP in R&D today versus 1.9 percent in 1964. The U.S. has fallen to 14th globally in public investment in science and technology as a percentage of GDP. There is, however, a growing recognition that existential societal challenges, as well as maintaining global competitiveness, demand that we dramatically elevate U.S. investment in science and technology.

March 24, 2021 · Morning Consult arrow icon

In the U.S.-China Competition Over Science and Technology, Only One Is In the Running

Competition among scientists and nations could end Alzheimer’s disease, cancer and AIDS, keep our nation technologically secure and help us feed and power the world as we address climate change. But instead of investing in the science and technology to maintain our competitive edge, U.S. investments are waning as China’s advantage has grown.

March 17, 2021 · Wall St Journal Opinion arrow icon

U.S. Must Not Fall Behind China in Research

Falling behind in R&D would hinder our ability to attract top science, technology, engineering and mathematics students and talent from the U.S. and abroad and continue to compete in the global economic arena.

January 20, 2021 · Washington Post Letters to the Editor arrow icon

Opinion: Supporting and funding science at the top is critical

The Jan. 20 news article “Biden to give White House science office Cabinet status” reported on the Biden administration’s plan to elevate the importance of science and technology to tackle the greatest challenges of our time — from food, water and energy security to the threat of further pandemics to climate challenges. President Biden should be lauded for taking this important step, which will bring rigorous scientific thinking to the highest level of government, and he should be congratulated for bringing together top scientific minds to lead the White House science team, including the nomination of Eric Lander to Office of Science and Technology Policy director.

January 19, 2021 · Futurism arrow icon

Here’s How Biden Could Save the Coronavirus Vaccine Rollout

To figure out how he can reach his goals, Futurism asked numerous public health experts how the Biden administration will be able to turn the vaccination campaign around. Here are the steps they outlined.

January 15, 2021 · The Hill arrow icon

The US government’s best ally: Science

One of the greatest scientific achievements of the past century — the rapid development of safe, effective COVID-19 vaccines — happened because the United States broke with convention. A unique public and private sector collaboration, built on the foundations of decades of federal basic science support and fueled by urgency and an infusion of funds, unleashed the best America has to offer.

January 14, 2021 · Politico arrow icon

Politico Morning Tech

The nonpartisan Science and Technology Action Committee wrote a letter urging the Biden transition team to elevate Office of Science and Technology Policy leadership to the Cabinet level.

The Science & Technology Action Committee is a group of 22 non-profit, academic, foundation, and corporate leaders working to dramatically strengthen U.S. science and technology. The Committee is co-chaired by: Keith Yamamoto, Vice Chancellor for Science Policy & Strategy UCSF, Sudip Parikh, CEO, The American Association for the Advancement of Science (AAAS), and Mary Woolley, President & CEO, Research!America.